Bacterin Intl Hldgs (BONE) 4.20 $BONE
Bacterin Internationals' (BONE) CEO Dan Goldberger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 18, 2:41PM CDT
BONE: 4.20 (-0.04)
Bacterin International net loss improves in Q4 and FY14
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 7:26AM CDT
BONE: 4.20 (-0.04)
Bacterin's full-year guidance exceeds analyst estimates
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:44PM CDT
BONE: 4.20 (-0.04)
Bacterin International misses by $0.14, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:31PM CDT
BONE: 4.20 (-0.04)
Bacterin Announces Contract Extension With Novation
GlobeNewswire - Mon Mar 16, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced that it has extended its contract with Novation for an additional year. The extension will allow Bacterin to continue to supply Novation members with OsteoSponge, OsteoSelect DBM Putty, and other proprietary Bacterin allografts.
BONE: 4.20 (-0.04)
Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference
GlobeNewswire - Wed Mar 11, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger, will present at the Canaccord Genuity Musculoskeletal Conference, to be held March 24, 2015 at the MGM Grand in Las Vegas, NV. Bacterin's presentation will take place Tuesday, March 24, 2015 at 2:00pm PT.
BONE: 4.20 (-0.04)
Bacterin inks deal with federal government-focused distributor
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 7:42AM CDT
BONE: 4.20 (-0.04)
Bacterin Announces Distribution Agreement With Spartan Medical for DOD and VA Medical Centers
GlobeNewswire - Tue Mar 10, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced it has signed a national distribution agreement with Spartan Medical, Inc., a service-disabled, veteran-owned, small business focused on distribution to government medical facilities.
BONE: 4.20 (-0.04)
Bacterin to Report Fourth Quarter 2014 Financial Results on March 17, 2015
GlobeNewswire - Mon Mar 02, 1:30PM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period and full year ended December 31, 2014, on March 17, 2015 at the close of the financial markets.
BONE: 4.20 (-0.04)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 11:45AM CST
BNSO: 1.52 (+0.06), BONE: 4.20 (-0.04), FUEL: 9.70 (-0.13), ASTI: 1.30 (-0.01), AHS: 22.15 (-0.05), AXN: 1.72 (-0.15), EGRX: 41.00 (-0.11), NBG: 1.34 (+0.14), GTT: 18.75 (-0.05), WBAI: 11.06 (+1.08), GENE: 3.88 (-0.09), EGLT: 15.40 (-0.22), SAAS: 11.58 (+0.34), CLRX: 1.07 (-0.05), CAS: 3.64 (+0.11), NDLS: 18.32 (+0.12), TRUE: 17.37 (-0.54), HOTR: 2.59 (-0.10), SZMK: 7.83 (-0.15), BLDR: 6.28 (+0.26)
4 Health Care Stocks Under $10 to Watch: ImmunoGen, Bacterin and More
at The Street - Thu Feb 19, 12:23PM CST
Keep these under-$10 health care stocks on your trading radar.
BONE: 4.20 (-0.04), PHMD: 1.79 (+0.04), IMGN: 7.44 (-0.48), SNSS: 2.60 (-0.04)
What's New in the Biotechnology Sector: Special Research on Vical,Asterias, Bacterin, Hemispherx BioPharma, and IGI Laboratories
PR Newswire - Thu Feb 19, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
VICL: 0.97 (+0.01), BONE: 4.20 (-0.04), HEB: 0.22 (-0.01), AST: 7.88 (-0.40), IG: 9.32 (+0.65)
Bacterin Announces 1000th Lot of OsteoSelect(R) DBM Putty
GlobeNewswire - Tue Feb 17, 6:30AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it has eclipsed an operational milestone processing over 1000 lots of OsteoSelect DBM Putty.
BONE: 4.20 (-0.04)
Bacterin reports preliminary results
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 8:52AM CST
BONE: 4.20 (-0.04)
Bacterin Announces Preliminary Fourth Quarter 2014 Revenue
GlobeNewswire - Mon Jan 12, 8:15AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary unaudited revenue for the fourth quarter of 2014.
BONE: 4.20 (-0.04)
Bacterin to Present at the 7th Annual LD Micro Conference
GlobeNewswire - Wed Nov 26, 6:30AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the LD Micro Conference 7th Annual Main Event, to be held December 4, 2014 at the Luxe Hotel in Los Angeles, CA. Bacterin's presentation will take place Thursday, December 4, 2014 at 1:30pm PT.
BONE: 4.20 (-0.04)
Stocks to watch ahead of the "Best of the Uncovereds" conference
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 6:45AM CST
ACET: 21.89 (-0.28), ACU: 18.25 (-0.17), BONE: 4.20 (-0.04), MNTX: 9.47 (+0.46), TREC: 12.31 (+0.30), INTL: 30.44 (+0.88), HPJ: 5.27 (-0.04), SPA: 24.96 (+1.01), AXPW: 0.06 (-0.01), DXPE: 45.08 (+0.61), LODE: 0.61 (-0.04), LABL: 70.92 (+0.20), NEWT: 18.86 (-0.14), SA: 6.29 (-0.07), PSEC: 8.56 (+0.05)
Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference
GlobeNewswire - Mon Nov 17, 11:54AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday, November 20, 2014 at 10:30am ET.
BONE: 4.20 (-0.04)
Bacterin Internationals' (BONE) CEO Dan Goldberger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 18, 2:41PM CDT
BONE: 4.20 (-0.04)
Bacterin International net loss improves in Q4 and FY14
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 7:26AM CDT
BONE: 4.20 (-0.04)
Bacterin's full-year guidance exceeds analyst estimates
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:44PM CDT
BONE: 4.20 (-0.04)
Bacterin International misses by $0.14, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:31PM CDT
BONE: 4.20 (-0.04)
Bacterin Announces Contract Extension With Novation
GlobeNewswire - Mon Mar 16, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced that it has extended its contract with Novation for an additional year. The extension will allow Bacterin to continue to supply Novation members with OsteoSponge, OsteoSelect DBM Putty, and other proprietary Bacterin allografts.
BONE: 4.20 (-0.04)
Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference
GlobeNewswire - Wed Mar 11, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger, will present at the Canaccord Genuity Musculoskeletal Conference, to be held March 24, 2015 at the MGM Grand in Las Vegas, NV. Bacterin's presentation will take place Tuesday, March 24, 2015 at 2:00pm PT.
BONE: 4.20 (-0.04)
Bacterin inks deal with federal government-focused distributor
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 7:42AM CDT
BONE: 4.20 (-0.04)
Bacterin Announces Distribution Agreement With Spartan Medical for DOD and VA Medical Centers
GlobeNewswire - Tue Mar 10, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced it has signed a national distribution agreement with Spartan Medical, Inc., a service-disabled, veteran-owned, small business focused on distribution to government medical facilities.
BONE: 4.20 (-0.04)
Bacterin to Report Fourth Quarter 2014 Financial Results on March 17, 2015
GlobeNewswire - Mon Mar 02, 1:30PM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period and full year ended December 31, 2014, on March 17, 2015 at the close of the financial markets.
BONE: 4.20 (-0.04)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 11:45AM CST
BNSO: 1.52 (+0.06), BONE: 4.20 (-0.04), FUEL: 9.70 (-0.13), ASTI: 1.30 (-0.01), AHS: 22.15 (-0.05), AXN: 1.72 (-0.15), EGRX: 41.00 (-0.11), NBG: 1.34 (+0.14), GTT: 18.75 (-0.05), WBAI: 11.06 (+1.08), GENE: 3.88 (-0.09), EGLT: 15.40 (-0.22), SAAS: 11.58 (+0.34), CLRX: 1.07 (-0.05), CAS: 3.64 (+0.11), NDLS: 18.32 (+0.12), TRUE: 17.37 (-0.54), HOTR: 2.59 (-0.10), SZMK: 7.83 (-0.15), BLDR: 6.28 (+0.26)
4 Health Care Stocks Under $10 to Watch: ImmunoGen, Bacterin and More
at The Street - Thu Feb 19, 12:23PM CST
Keep these under-$10 health care stocks on your trading radar.
BONE: 4.20 (-0.04), PHMD: 1.79 (+0.04), IMGN: 7.44 (-0.48), SNSS: 2.60 (-0.04)
What's New in the Biotechnology Sector: Special Research on Vical,Asterias, Bacterin, Hemispherx BioPharma, and IGI Laboratories
PR Newswire - Thu Feb 19, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
VICL: 0.97 (+0.01), BONE: 4.20 (-0.04), HEB: 0.22 (-0.01), AST: 7.88 (-0.40), IG: 9.32 (+0.65)
Bacterin Announces 1000th Lot of OsteoSelect(R) DBM Putty
GlobeNewswire - Tue Feb 17, 6:30AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it has eclipsed an operational milestone processing over 1000 lots of OsteoSelect DBM Putty.
BONE: 4.20 (-0.04)
Bacterin reports preliminary results
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 8:52AM CST
BONE: 4.20 (-0.04)
Bacterin Announces Preliminary Fourth Quarter 2014 Revenue
GlobeNewswire - Mon Jan 12, 8:15AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary unaudited revenue for the fourth quarter of 2014.
BONE: 4.20 (-0.04)
Bacterin to Present at the 7th Annual LD Micro Conference
GlobeNewswire - Wed Nov 26, 6:30AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the LD Micro Conference 7th Annual Main Event, to be held December 4, 2014 at the Luxe Hotel in Los Angeles, CA. Bacterin's presentation will take place Thursday, December 4, 2014 at 1:30pm PT.
BONE: 4.20 (-0.04)
Stocks to watch ahead of the "Best of the Uncovereds" conference
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 6:45AM CST
ACET: 21.89 (-0.28), ACU: 18.25 (-0.17), BONE: 4.20 (-0.04), MNTX: 9.47 (+0.46), TREC: 12.31 (+0.30), INTL: 30.44 (+0.88), HPJ: 5.27 (-0.04), SPA: 24.96 (+1.01), AXPW: 0.06 (-0.01), DXPE: 45.08 (+0.61), LODE: 0.61 (-0.04), LABL: 70.92 (+0.20), NEWT: 18.86 (-0.14), SA: 6.29 (-0.07), PSEC: 8.56 (+0.05)
Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference
GlobeNewswire - Mon Nov 17, 11:54AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday, November 20, 2014 at 10:30am ET.
BONE: 4.20 (-0.04)
